Delix
Delix is harnessing the power of a novel class of compounds known as neuroplastogens, to bring about a new paradigm in brain health therapeutics: treatments intended to be safe, fast acting, and long lasting for those that need them most.
Series A ·
Amount not disclosed in a source on record.
All 2 rounds ↓Signals
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Round | undisclosed | endpoints.news | ||
| Series A | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
- DODavid Olson Co-Foundersource: delixtherapeutics.com
NH
Nick Haft FounderES
Eliseo Salinas Head of Research And DevelopmentMR
Mark Rus Chief Executive OfficerMG
Matt Gorman Chief Financial OfficerRM
Retsina Meyer Head of Strategic Projects and AlliancesTM
Tricia McCall Chief People Officer
Investors
AAdage Capital Management
AARTIS Ventures
BBail Capital
DDementia Discovery Fundlead investor
DDolby Family Ventures
HHamilton Square Partners Management
JJohnson & Johnson Innovationlead investor
OOMX Ventures
RRA Capital Management
UUC Davis Health Ventures
VVestal Point Capital
YYK Bioventures
Companies like Delix
BBelhaven Biopharma$10M Series A · Aug 2025
FF2G$100M Series B+ · Sep 2024
KKnown Medicine$7.2M Seed · Aug 2021
SSynthekine$100M Series B+ · Jan 2023
AAtavistik Bio$40M Series B+ · Mar 2026
LLassen Therapeutics$85M Series B+ · Jan 2024
Other companies backed by Dementia Discovery Fund
TTRIMTECH Therapeutics$14M Seed · Jun 2026
NNRG Therapeutics$67M Series B+ · Sep 2025
TTherini BioSeries A · May 2026
LLoQus23Series A · Oct 2024
Dementia Discovery Fund portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/delix (get a free API key).